Replies to post #236799 on Biotech Values

[DewDiligence]

RSLS reverse-merges with—(private)—Vyome Therapeutics:

https://finance.yahoo.com/news/reshape-lifesciences-enters-merger-agreement-123100413.html

…existing ReShape stockholders will own approximately 11.1% of the combined company immediately following the closing of the merger… At the closing of the merger, ReShape will be renamed Vyome Holdings, Inc. and expects to trade under the Nasdaq ticker symbol “HIND”…

I.e., RSLS is essentially getting paid for its Nasdaq listing and nothing more.

…Vyome Therapeutics, Inc. is a clinical stage specialty pharmaceutical company working to treat immuno-inflammatory diseases including rare indications of unmet need… RSLS is yet another “serial” reverse-merger company, having been created by a reverse-merger with OBLN in 2021 (#msg-161068114).